Literature DB >> 19764816

Transition state analogues rescue ribosomes from saporin-L1 ribosome inactivating protein.

Matthew B Sturm1, Peter C Tyler, Gary B Evans, Vern L Schramm.   

Abstract

Ribosome inactivating proteins (RIPs) catalyze the hydrolytic depurination of one or more adenosine residues from eukaryotic ribosomes. Depurination of the ribosomal sarcin-ricin tetraloop (GAGA) causes inhibition of protein synthesis and cellular death. We characterized the catalytic properties of saporin-L1 from Saponaria officinalis (soapwort) leaves, and it demonstrated robust activity against defined nucleic acid substrates and mammalian ribosomes. Transition state analogue mimics of small oligonucleotide substrates of saporin-L1 are powerful, slow-onset inhibitors when adenosine is replaced with the transition state mimic 9-deazaadenine-9-methylene-N-hydroxypyrrolidine (DADMeA). Linear, cyclic, and stem-loop oligonucleotide inhibitors containing DADMeA and based on the GAGA sarcin-ricin tetraloop gave slow-onset tight-binding inhibition constants (K(i)*) of 2.3-8.7 nM under physiological conditions and bind up to 40000-fold tighter than RNA substrates. Saporin-L1 inhibition of rabbit reticulocyte translation was protected by these inhibitors. Transition state analogues of saporin-L1 have potential in cancer therapy that employs saporin-L1-linked immunotoxins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19764816      PMCID: PMC2762729          DOI: 10.1021/bi901425h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

1.  Non-specific depurination activity of saporin-S6, a ribosome-inactivating protein, under acidic conditions.

Authors:  S Tang; R G Hu; W Y Liu; K C Ruan
Journal:  Biol Chem       Date:  2000-08       Impact factor: 3.915

2.  The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage.

Authors:  R Baluna; E Coleman; C Jones; V Ghetie; E S Vitetta
Journal:  Exp Cell Res       Date:  2000-08-01       Impact factor: 3.905

3.  Mass spectrometric study of different isoforms of the plant toxin saporin.

Authors:  F De Angelis; A Di Tullio; L Spanò; A Tucci
Journal:  J Mass Spectrom       Date:  2001-11       Impact factor: 1.982

4.  Microtiter-based assay for evaluating the biological activity of ribosome-inactivating proteins.

Authors:  M L Hale
Journal:  Pharmacol Toxicol       Date:  2001-05

5.  Enzymatic activity of toxic and non-toxic type 2 ribosome-inactivating proteins.

Authors:  Luigi Barbieri; Marialibera Ciani; Tomás Girbés; Wang-Yi Liu; Els J M Van Damme; Willy J Peumans; Fiorenzo Stirpe
Journal:  FEBS Lett       Date:  2004-04-09       Impact factor: 4.124

6.  Polynucleotide: adenosine glycosidase activity of immunotoxins containing ribosome-inactivating proteins.

Authors:  L Barbieri; A Bolognesi; P Valbonesi; L Polito; F Olivieri; F Stirpe
Journal:  J Drug Target       Date:  2000       Impact factor: 5.121

7.  Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice.

Authors:  Joan E Smallshaw; Victor Ghetie; Jose Rizo; John R Fulmer; Linda L Trahan; Maria-Ana Ghetie; Ellen S Vitetta
Journal:  Nat Biotechnol       Date:  2003-03-10       Impact factor: 54.908

8.  Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma.

Authors:  R Schnell; P Borchmann; J O Staak; J Schindler; V Ghetie; E S Vitetta; A Engert
Journal:  Ann Oncol       Date:  2003-05       Impact factor: 32.976

9.  Saporin induces multiple death pathways in lymphoma cells with different intensity and timing as compared to ricin.

Authors:  Letizia Polito; Massimo Bortolotti; Valentina Farini; Maria Giulia Battelli; Luigi Barbieri; Andrea Bolognesi
Journal:  Int J Biochem Cell Biol       Date:  2008-09-30       Impact factor: 5.085

10.  Detecting ricin: sensitive luminescent assay for ricin A-chain ribosome depurination kinetics.

Authors:  Matthew B Sturm; Vern L Schramm
Journal:  Anal Chem       Date:  2009-04-15       Impact factor: 6.986

View more
  14 in total

1.  Transition state analogues in structures of ricin and saporin ribosome-inactivating proteins.

Authors:  Meng-Chiao Ho; Matthew B Sturm; Steven C Almo; Vern L Schramm
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

2.  Profiling base excision repair glycosylases with synthesized transition state analogs.

Authors:  Aurea M Chu; James C Fettinger; Sheila S David
Journal:  Bioorg Med Chem Lett       Date:  2011-05-30       Impact factor: 2.823

Review 3.  Enzymatic transition states, transition-state analogs, dynamics, thermodynamics, and lifetimes.

Authors:  Vern L Schramm
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

4.  Oligonucleotide transition state analogues of saporin L3.

Authors:  Jennifer M Mason; Hongling Yuan; Gary B Evans; Peter C Tyler; Quan Du; Vern L Schramm
Journal:  Eur J Med Chem       Date:  2016-10-27       Impact factor: 6.514

5.  Soapwort Saporin L3 Expression in Yeast, Mutagenesis, and RNA Substrate Specificity.

Authors:  Hongling Yuan; Quan Du; Matthew B Sturm; Vern L Schramm
Journal:  Biochemistry       Date:  2015-07-14       Impact factor: 3.162

6.  Cracking down on inhibition: selective removal of GABAergic interneurons from hippocampal networks.

Authors:  Flavia Antonucci; Alán Alpár; Johannes Kacza; Matteo Caleo; Claudia Verderio; Alice Giani; Henrik Martens; Farrukh A Chaudhry; Manuela Allegra; Jens Grosche; Dominik Michalski; Christian Erck; Anke Hoffmann; Tibor Harkany; Michela Matteoli; Wolfgang Härtig
Journal:  J Neurosci       Date:  2012-02-08       Impact factor: 6.167

Review 7.  Transition States, analogues, and drug development.

Authors:  Vern L Schramm
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

8.  Transition State Structure of RNA Depurination by Saporin L3.

Authors:  Hongling Yuan; Christopher F Stratton; Vern L Schramm
Journal:  ACS Chem Biol       Date:  2016-03-08       Impact factor: 5.100

Review 9.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622

10.  Small-molecule inhibitor leads of ribosome-inactivating proteins developed using the doorstop approach.

Authors:  Yuan-Ping Pang; Jewn Giew Park; Shaohua Wang; Anuradha Vummenthala; Rajesh K Mishra; John E McLaughlin; Rong Di; Jennifer Nielsen Kahn; Nilgun E Tumer; Laszlo Janosi; Jon Davis; Charles B Millard
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.